Large-scale study shows oral hydroxychloroquine and povidone-iodine throat spray can reduce spread of Covid-19 in high transmission settings

For medical and trade media only

Please refer to the official media release from the National University Health System in Singapore.

IMPORTANT INFORMATION:  Mundipharma’s brand of povidone-iodine throat spray, (Betadine® Throat Spray), is only indicated for use by adults and children aged 6 years and older, up to 3 sprays per day for a maximum of seven (7) days or as directed by a healthcare professional. Dosage instructions may vary by country due to local regulatory approvals. Betadine® Throat Spray is not currently authorised for the prevention or treatment of COVID-19.

It is advisable to speak to a doctor if you have a thyroid condition, allergies to povidone-iodine or any ingredients in the product, if you are pregnant or breast feeding, or for usage in children.